Oxford Pharmascience is a specialty consumer health company using proprietary formulation and drug delivery technologies to develop and commercialise products that are better, safer and easier to take.
Oxford Pharmascience Ltd was formed from the demerger of Oxford Pharmascience Group Plc with the objective of continuing the commercialisation of the OXPZero™ NSAIDs assets and the further development of its food supplement business.
The Company currently commercialises calcium/vitamin D chews that taste better and dissolve faster than currently available regular formats. These products are now marketed in the UK, Far East and Latin America.
Oxford Pharmascience is located in the UK and is led by a highly experienced management team that directs and manages the outsourcing of its development; pre-clinical and clinical programs; and manufacturing to a trusted network of partners and suppliers.
The Company commercialises its portfolio of product opportunities through out-licensing to leading pharmaceutical companies worldwide as well as through its own Ellactiva® brand .
If you require any further information then please feel free to contact us using email@example.com.